- Letter: Association between Serum Dipeptidyl Peptidase-4 Concentration and Obesity-Related Factors in Health Screen Examinees (J Obes Metab Syndr 2017;26:188-96)
-
Koh G
- KMID: 2410878
- J Obes Metab Syndr.
- 2018 Mar;27(1):71-72.
- doi: 10.7570/jomes.2018.27.1.71
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Non-glycemic Effects of SGLT2 Inhibitor
-
Lee DH
- KMID: 2173888
- J Korean Diabetes.
- 2014 Sep;15(3):151-157.
- doi: 10.4093/jkd.2014.15.3.151
Sodium glucose cotransporter 2 (SGLT2) inhibitors have recently been introduced as a new class of anti-diabetic agents. In addition to their glycemic action, SGLT2 inhibitors also have a number of... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Glucagon Like Peptide-1 (GLP-1) Analogues
-
Chun HJ, Kwon HS
- KMID: 2173920
- J Korean Diabetes.
- 2013 Sep;14(3):125-127.
- doi: 10.4093/jkd.2013.14.3.125
Recently, incretin hormone-based therapies, including glucagon-like peptide-1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors, have become the main therapeutic tools in the hyperglycemia management in patients with type 2 diabetes... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in Glucose Metabolism with Aging
-
Hong EG
- KMID: 2468008
- J Korean Diabetes.
- 2019 Dec;20(4):215-219.
- doi: 10.4093/jkd.2019.20.4.215
The increasing risk of glucose intolerance and diabetes associated with aging is well established. However, it is difficult to determine whether changes in glucose metabolism result from biological aging itself... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of DPP-4 Inhibitors
-
Kim NH, Kim SG
- KMID: 2173918
- J Korean Diabetes.
- 2013 Sep;14(3):111-119.
- doi: 10.4093/jkd.2013.14.3.111
During past several years, a novel class of antihyperglycemic agents, dipeptidyl peptidase-4 (DPP-4) inhibitors, has become one of the most important options in the management of type 2 diabetes. These... -
- CITED
-
- Close
- SHARE
-
- Close
- In Vivo Models for Incretin Research: From the Intestine to the Whole Body
-
Oh TJ
- KMID: 2169691
- Endocrinol Metab.
- 2016 Mar;31(1):45-51.
- doi: 10.3803/EnM.2016.31.1.45
Incretin hormones are produced by enteroendocrine cells (EECs) in the intestine in response to ingested nutrient stimuli. The incretin effect is defined as the difference in the insulin secretory response... -
- CITED
-
- Close
- SHARE
-
- Close
- The Incretins and Pancreatic beta-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus
-
Kim MH, Lee MK
- KMID: 2298038
- Korean Diabetes J.
- 2010 Feb;34(1):2-9.
- doi: 10.4093/kdj.2010.34.1.2
Type 2 diabetes mellitus (T2DM) is increasing in prevalence worldwide. The complications associated with T2DM result in increased mortality and financial cost for those affected. T2DM has long been known... -
- CITED
-
- Close
- SHARE
-
- Close
- Pleiotropic Effects of an Incretin Hormone
-
Oh S
- KMID: 2173919
- J Korean Diabetes.
- 2013 Sep;14(3):120-124.
- doi: 10.4093/jkd.2013.14.3.120
The incretin hormones glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) have recently received much attention for their roles in type 2 diabetes therapy. GLP-1 stimulated insulin secretion in... -
- CITED
-
- Close
- SHARE
-
- Close
- Glucose-Lowering Agents in the Management of Nonalcoholic Fatty Liver Disease
-
Yang H, Park CY
- KMID: 2415852
- J Korean Diabetes.
- 2018 Jun;19(2):88-96.
- doi: 10.4093/jkd.2018.19.2.88
Nonalcoholic fatty liver disease (NAFLD) is more prevalent in diabetic patients than in non-diabetic subjects, because the two diseases share a common pathophysiological mechanism. Associated abnormalities can be observed from... -
- CITED
-
- Close
- SHARE
-
- Close
- Mechanism and Efficacy of New Anti-diabetic Medications
-
Kwon HS
- KMID: 2173950
- J Korean Diabetes.
- 2012 Dec;13(4):167-171.
- doi: 10.4093/jkd.2012.13.4.167
Previously proposed main pathogenic mechanisms for type 2 diabetes mellitus (T2DM) are increased hepatic glucose production, insulin resistance and insulin secretion defect. However, further mechanisms involved in the development of... -
- CITED
-
- Close
- SHARE
-
- Close
- Response: Association between Serum Dipeptidyl Peptidase-4 Concentration and Obesity-Related Factors in Health Screen Examinees (J Obes Metab Syndr 2017;26:188-96)
-
Lee JY, Jang BK, Song MK, Kim HS, Kim MK
- KMID: 2410879
- J Obes Metab Syndr.
- 2018 Mar;27(1):73-74.
- doi: 10.7570/jomes.2018.27.1.73
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Glucagon-Like Peptide-1 (GLP-1) Agonist
-
Eom YS, Kim BJ
- KMID: 2269256
- Korean J Med.
- 2014 Jul;87(1):9-13.
The prevalence of diabetes is increasing worldwide. Glycemic control has been shown to prevent microvascular complications. Many oral hyperglycemic drugs and insulin are being used in the treatment of diabetes,... -
- CITED
-
- Close
- SHARE
-
- Close
- Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss
-
Gavrieli A, Mantzoros
- KMID: 2352973
- Endocrinol Metab.
- 2016 Sep;31(3):361-372.
- doi: 10.3803/EnM.2016.31.3.361
Excess energy intake, without a compensatory increase of energy expenditure, leads to obesity. Several molecules are involved in energy homeostasis regulation and new ones are being discovered constantly. Appetite regulating... -
- CITED
-
- Close
- SHARE
-
- Close
- Understanding the Cardiovascular Effects of Incretin
-
Yoon JS, Lee HW
- KMID: 1857497
- Diabetes Metab J.
- 2011 Oct;35(5):437-443.
- doi: 10.4093/dmj.2011.35.5.437
Cardiovascular disease (CVD), a leading cause of death in patients with diabetes mellitus, has several pathogenic mechanisms that are well established. However, the traditional hypoglycemic agents do not have proven... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Nutrient Preload and Food Order on Glucose, Insulin, and Gut Hormones
-
Bae JH, Cho YM
- KMID: 2442357
- J Korean Diabetes.
- 2018 Dec;19(4):193-199.
- doi: 10.4093/jkd.2018.19.4.193
Postprandial hyperglycemia is associated with the risk of diabetes mellitus, cardiovascular disease, and mortality. Nutrition therapy is an important component of the management of postprandial hyperglycemia. Postprandial glucose levels are... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacotherapy for Postprandial Hyperglycemia in Type 2 Diabetes
-
Yoo HJ
- KMID: 1436186
- J Korean Diabetes.
- 2012 Mar;13(1):39-43.
- doi: 10.4093/jkd.2012.13.1.39
A growing body of evidence shows that effective postprandial hyperglycemia management in individuals with type 2 diabetes can reduce the risk of diabetic complications and cardiovascular diseases. Therefore, accurate monitoring... -
- CITED
-
- Close
- SHARE
-
- Close
- New therapeutic agents in diabetic nephropathy
-
Kim Y, Park CW
- KMID: 2365975
- Korean J Intern Med.
- 2017 Jan;32(1):11-25.
- doi: 10.3904/kjim.2016.174
Studies investigating diabetic nephropathy (DN) have mostly focused on interpreting the pathologic molecular mechanisms of DN, which may provide valuable tools for early diagnosis and prevention of disease onset and... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Efficacy of Dipeptidylpeptidase-4 Inhibitors Between Asian and Non-Asian Populations
-
Kim YG, Cho YM
- KMID: 2173922
- J Korean Diabetes.
- 2013 Sep;14(3):133-137.
- doi: 10.4093/jkd.2013.14.3.133
Type 2 diabetes is different between Asian and non-Asian populations. Compared with their Caucasian counterparts, Asian patients with type 2 diabetes have the characteristics of lower body mass index, lower... -
- CITED
-
- Close
- SHARE
-
- Close
- New and emerging drugs in type 2 diabetes
-
Park IB
- KMID: 2256406
- Korean J Med.
- 2007 May;72(5):446-450.
Recent advances in understanding insulin secretion, action and signaling have led to the development of new pharmacological agents. Several new emerging drugs and drug classes for the management of diabetes... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Application of Glucagon-Like Peptide-1 Receptor Agonists
-
Min SH, Cho YM
- KMID: 2173851
- J Korean Diabetes.
- 2015 Dec;16(4):252-259.
- doi: 10.4093/jkd.2015.16.4.252
Glucagon-like peptide 1 (GLP-1) is an incretin hormone that is released from enteroendocrine L-cells upon nutrient absorption; it stimulates glucose-dependent insulin secretion from pancreatic betacells. GLP-1 has pleiotropic effects including... -
- CITED
-
- Close
- SHARE
-
- Close
